Syrenicz A, Goździk J, Pynka S, Pilarska K, Gruszczyńska M, Gołebiowska I, Syrenicz M, Miazgowski T, Listewnik M, Krzyzanowska B
Klinika Endokrynologii i Chorób Przemiany Materii PAM w Szczecinie.
Endokrynol Pol. 1991;42(2):299-309.
The study, supported by program MZ-XVII, was carried on 4567 inhabitants of the area of Szczecin (2350 females and 2217 males). The population was chosen randomly, according to a simple drawing scheme. All subjects were clinically examined using standardised questionnaires. In 3468 persons (including 1807 girls and women, 1661 boys and men) apart form clinical examination, the assessment of thyrotropin, thyroxine and triiodothyronine in serum and frequency of antithyroglobulin antibodies and antithyroid membrane antibodies were evaluated. The data indicate that 94% of children in Szczecin's region received the prophylactic dose of iodine, mostly between the 1st and the 5th of May 1986. Only 17% of the adults received iodine. The most common preparation was Lugol solution given in a single dose. Among all persons who received iodine, only in 5% of subjects the side effects were noted (mostly in children), including symptoms of gastrointestinal tract (vomiting, abdomen pain) and occasionally intrathyroid side effects (thyroid pains). In examined population the high frequency of thyroid enlargement, mainly in women (up to 43-44% at the age group 30-50 years) was found. The frequency of clinical diagnosis of thyroid disease was higher in women than in man (most often the diffuse goiter, rarely the nodular goiter). The frequency of thyroid enlargement and clinical diagnosis of thyroid disease was not dependent on prophylactic iodine intake. The iodine prophylaxis did not influence on thyroid hormones and TSH serum levels and on frequency of antithyroid antibodies.
该研究由MZ-XVII项目资助,对什切青地区的4567名居民(2350名女性和2217名男性)进行。根据简单抽签方案随机选取该人群。所有受试者均使用标准化问卷进行临床检查。在3468人(包括1807名女孩和妇女、1661名男孩和男子)中,除临床检查外,还评估了血清促甲状腺激素、甲状腺素和三碘甲状腺原氨酸水平以及抗甲状腺球蛋白抗体和抗甲状腺膜抗体的频率。数据表明,什切青地区94%的儿童接受了预防性碘剂量,大多在1986年5月1日至5日期间。只有17%的成年人接受了碘。最常用的制剂是单次服用的卢戈氏溶液。在所有接受碘的人中,只有5%的受试者出现了副作用(主要是儿童),包括胃肠道症状(呕吐、腹痛),偶尔还有甲状腺内副作用(甲状腺疼痛)。在所检查的人群中,发现甲状腺肿大的发生率很高,主要是女性(30至50岁年龄组高达43%-44%)。甲状腺疾病的临床诊断频率女性高于男性(最常见的是弥漫性甲状腺肿,很少是结节性甲状腺肿)。甲状腺肿大的频率和甲状腺疾病的临床诊断与预防性碘摄入无关。碘预防对甲状腺激素和TSH血清水平以及抗甲状腺抗体的频率没有影响。